Should serum voriconazole (Vori) levels be monitored in allogeneic hematopoietic stem cell transplant (HSCT) recipients?

被引：0
|
作者：
Trifilio, S
Ortiz, R
Pennick, G
Pi, J
Verma, A
Mehta, J
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
291
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [1] Post marketing surveillance of voriconazole (VORI) use in hematopoietic stem cell transplant (HSCT) recipients at a single academic institution
    Leather, HL
    Pazzalia, A
    Corey, M
    Wingard, JR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 105 - 105
  • [2] Tacrolimus dosing in allogeneic hematopoietic stem cell transplant (HSCT) recipients receiving concomitant voriconazole.
    Trifilio, Steven
    Pi, Judy
    Singhal, Seema
    Frankfurt, Olga
    Evens, Andrew
    Gordon, Leo
    Tallman, Martin
    Winter, Jane
    Williams, Stephanie
    Mehta, Jayesh
    BLOOD, 2007, 110 (11) : 315B - 315B
  • [3] Immune Deficits in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Mir, Muhammad A.
    Battiwalla, Minoo
    MYCOPATHOLOGIA, 2009, 168 (06) : 271 - 282
  • [4] Immune Deficits in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Muhammad A. Mir
    Minoo Battiwalla
    Mycopathologia, 2009, 168 : 271 - 282
  • [5] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    S Trifilio
    R Ortiz
    G Pennick
    A Verma
    J Pi
    V Stosor
    T Zembower
    J Mehta
    Bone Marrow Transplantation, 2005, 35 : 509 - 513
  • [6] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    Trifilio, S
    Ortiz, R
    Pennick, G
    Verma, A
    Pi, J
    Stosor, V
    Zembower, T
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 509 - 513
  • [7] Incidence of Fluoride Toxicity in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients Taking Voriconazole
    Ostrem, Megan
    Merten, Julianna
    Hogan, William
    Litzow, Mark R.
    Patnaik, Mrinal
    Hashmi, Shahrukh
    Bartoo, Gabriel
    Wolf, Robert
    Wermers, Robert
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S377 - S378
  • [8] Voriconazole plasma levels monitoring in allogeneic haematopoietic stem cell transplant recipients
    Winterova, J.
    Racil, Z.
    Malaskova, L.
    Kocmanova, I.
    Weinbergerova, B.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S242 - S242
  • [9] Zygomycosis in allogeneic hematopoietic stem cell transplant recipients receiving prophylactic voriconazole.
    De Magalhaes-Silverman, M
    Carter, T
    Gingrich, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 593S - 593S
  • [10] Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole
    Barajas, Megan R.
    McCullough, Kristen B.
    Merten, Julianna A.
    Dierkhising, Ross A.
    Bartoo, Gabriel T.
    Hashmi, Shahrukh K.
    Hogan, William J.
    Litzow, Mark R.
    Patnaik, Mrinal M.
    Wilson, John W.
    Wolf, Robert C.
    Wermers, Robert A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 579 - 583
12345